Lisa Suennen is Managing Partner at Venture Valkyrie Consulting, which provides business advisory services to large corporations, not-for-profit institutions, and venture capital and private equity firms in the healthcare field. Her advisory work focused on both investment and digital health strategy that capitalizes on the significant opportunities presented by today’s evolving healthcare system. Lisa is also Managing Member of Cardeation Capital Management.
Kyle Serikawa received his PhD in Genetics from the University of California at Berkeley in 1996 and moved to Seattle to pursue postdoctoral research positions in algal development and the cell cycle of yeast. He was an early adopter of microarrays as tools for the genome-wide measurement of transcription in cells and tissues.